Copyright:

All rights reserved.

This information may be freely used and copied for educational and other non-commercial purposes, provided that any reproduction of data be accompanied by an acknowledgement of EBOVAC2 as the source (© EBOVAC2). This does not apply to the pages and images with explicitly reserved reproduction right : © followed by the right owner and the year of first circulation. Reproduction of the latter requires prior authorization from EBOVBAC2 for the pages.

Privacy Policy :

Inserm Transfert will not to reveal information obtained from users. Such information is confidential and will only be used with users consent.

According to the Law n°78-17 "Informatique et Libertés/software and freedoms" and its amendments, users have the right to access, modify, correct and delete any personal data collected when visiting the site. The users can exercise such rights with:

INSERM TRANSFERT
7 rue de Watt
75013 Paris, FRANCE
©2015 EBOVAC2
Design & Programming: ML Com, France

News

  • 24 September 2018

    The 6th edition of the newsletter is available here. This issue contains an interview with Inserm's BSL-4 Laboratory director, Dr. Hervé Raoul. 

  • 24 September 2018

    The 5th EBOVAC2 newsletter March 2018 is available here. This issue includes an article on the training course conducted in Burkina Faso in January 2018.

  • 17 January 2018

    Clinical Trial Training - Bobo Dioulasso, BURKINA FASO, 23-26 January, 2018. For more information

  • 02 January 2018

    The 4th edition of our EBOVAC2 newlsetter was released on the 21st of December 2017.

  • 27 October 2017

    The 3rd EBOVAC2 Newsletter is now available here. Our October 2017 issue includes an interview with Dr Houreratou Barry, PI of the Centre Muraz site.

  • 12 September 2017

    The 3rd EBOVAC1/2 Annual meeting will be held in Amsteram, the Netherlands 8-10 January 2018. Participants include consortium members and representatives of sites where the project clinical trials are being carried out.

More news
  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research